Sanofi: Number of Employees 2006-2020 | SNY

Interactive chart of Sanofi (SNY) annual worldwide employee count from 2006 to 2020.
  • Sanofi total number of employees in 2019 was 100,409, a 3.66% decline from 2018.
  • Sanofi total number of employees in 2018 was 104,226, a 2.2% decline from 2017.
  • Sanofi total number of employees in 2017 was 106,566, a 0.27% decline from 2016.
  • Sanofi total number of employees in 2016 was 106,859, a 7.59% decline from 2015.
Sanofi Annual Number of Employees
2019 100,409
2018 104,226
2017 106,566
2016 106,859
2015 115,631
2014 113,496
2013 112,128
2012 111,974
2011 113,719
2010 101,575
2009 104,867
2008
2007
2006
2005
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $133.245B $40.002B
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $387.947B 18.49
Roche Holding AG (RHHBY) Switzerland $302.429B 0.00
Pfizer (PFE) United States $213.028B 13.32
Merck (MRK) United States $208.339B 14.90
Novartis AG (NVS) Switzerland $191.450B 14.88
Novo Nordisk (NVO) Denmark $154.051B 25.66
AstraZeneca (AZN) United Kingdom $149.117B 28.99
Eli Lilly (LLY) United States $146.187B 22.31
AbbVie (ABBV) United States $141.679B 10.32
GlaxoSmithKline (GSK) United Kingdom $103.577B 13.58
Bayer (BAYRY) Germany $64.831B 9.24
H Lundbeck (HLUYY) Denmark $7.412B 12.88
Innoviva (INVA) United States $1.399B 6.70